Stories from United States

Apple has acquired Color.io, a color grading tool developed by a single developer. The acquisition was disclosed in a January filing and is used by filmmakers and photographers.

AI company Anthropic has reportedly purchased millions of physical books, scanning them to create digital versions for training its AI systems. This move is part of its ongoing efforts to develop advanced language models.

A new Congressional Budget Office report projects that Donald Trump's proposed antimissile shield, referred to as 'Golden Dome,' would cost more than $1 trillion. This estimate is largely based on a previous executive order.

A lawsuit has been filed alleging that a teenager died after receiving recommendations for a deadly mix of drugs from ChatGPT. The case highlights concerns about the safety and accuracy of AI-generated advice.

Atlanta has been ranked as the top city for job market and affordability, according to a new index. The ranking considered factors like entry-level job availability, average starting salary, and housing affordability. Orlando, Austin, Tampa, and Miami also ranked highly.

Lionel Messi has doubled the base salary for Major League Soccer players. His total compensation of $28 million is more than double that of any other player in the league. The specific new salary figure was not disclosed.

The President stated his team will take action in March, aiming to benefit the Iranian people. This initiative is projected to be the highest since May 2023, excluding food and energy prices.

Memphis police have reported a reduction in homicides, with a 54% decrease. This marks a substantial improvement in public safety for the city, which previously had the highest per capita homicide rate in the country.

The Nitrogen ransomware gang has claimed responsibility for a hack targeting Foxconn earlier this month. Apple project files were allegedly stolen during a ransomware attack on Foxconn's North American facilities.

The head of the US Food and Drug Administration (FDA) is facing scrutiny, particularly regarding his handling of drug approvals. This comes amid broader concerns about the agency's processes.